Alexander C. Egbe*, Heidi M. Connolly*, Joseph T. Poterucha*,†, Carole A. Warnes*
Congenital Heart Disease, Vol.12, No.1, pp. 24-31, 2017
Abstract Objectives. There is a paucity of data about mixed aortic valve disease (MAVD) in patients with bicuspid/unicuspid
aortic valve (BAV). This study sought to describe the outcomes of patients with moderate/severe MAVD.
Methods. We queried our database for patients with BAV and moderate/severe MAVD seen between 1994 and
2013. We excluded patients with baseline New York Heart Association (NYHA) III/IV symptoms, left ventricular
ejection fraction <50%, aortic dimension >50 mm, and significant disease of other valves. The purpose of the study
was to determine the freedom from NYHA III/IV symptoms and aortic valve replacement (AVR).
Results. We identified… More >
Login
Register
